ÂÜÀòÂÒÂ×

Mr. Rutul R. Shah serves as Chief Operating Officer for Precigen. Mr. Shah has broad experience in alliance management, portfolio management, program and project management, and operations. Prior to joining Precigen, Mr. Shah spent more than a decade in scientific positions focused on the development of protein, antibody, gene, and cell therapy drugs at Zyngenia, Teva Biopharmaceuticals USA, CoGenesys, and Human Genome Sciences. Mr. Shah graduated with a BE degree in Chemical Engineering from Gujarat University in India and an MS degree in Bioengineering from the University of Illinois, Chicago.